ODDB.org: Open Drug Database

AbbVie AG - Constella, Kapseln

Swissmedic Registration	62684	Sequence	01
Product name	Constella	Description	Kapseln
ATC-Classification	A06AX04	ATC-Description	Linaclotide
Introduction of Sequence	20.06.2013

Composition

linaclotidum 0.29 mg, cellulosum microcristallinum, hypromellosum, calcii chloridum dihydricum, leucinum, Kapselhülle: gelatina, E 172 (rubrum), E 171, E 172 (flavum), macrogolum 3350, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 171, E 172 (nigrum), pro capsula.

Packungsbestandteile

Galenic Form

Capsules

Active Agent	Dose
Linaclotidum	0.29 mg

BAG: Active Agent	Dose
Linaclotidum	0.29 mg

Inactive agents	Dose	additional_information
(Flavum)
(Nigrum)
(Rubrum)
Ammoniae Solutio Concentrata
Calcii Chloridum Dihydricum
Cellulosum Microcristallinum
E 171		color.
E 172		color.
Gelatina		Kapselhülle
Hypromellosum
Kalii Hydroxidum
Lacca		Drucktinte
Leucin
Macrogol	3350
Pro Capsula
Propylenglycol

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
002	28 Capsule(s)	52.28	73.25	B	SL	No
004	90 Capsule(s)	142.84	171.75	B	SL	No

2025	©ywesee GmbH